Literature DB >> 21680886

Direct evidence for the formation of diastereoisomeric benzylpenicilloyl haptens from benzylpenicillin and benzylpenicillenic acid in patients.

Xiaoli Meng1, Rosalind E Jenkins, Neil G Berry, James L Maggs, John Farrell, Catherine S Lane, Andrew V Stachulski, Neil S French, Dean J Naisbitt, Munir Pirmohamed, B Kevin Park.   

Abstract

Covalent binding to proteins to form neoantigens is thought to be central to the pathogenesis of penicillin hypersensitivity reactions. We have undertaken detailed mass spectrometric studies to define the mechanism and protein chemistry of hapten formation from benzylpenicillin (BP) and its rearrangement product, benzylpenicillenic acid (PA). Mass spectrometric analysis of human serum albumin exposed to BP and PA in vitro revealed that at low concentrations (drug protein molar ratio 0.001:1) and during short time incubations BP and PA selectively target different residues, Lys199 and Lys525, respectively. Molecular modeling showed that the selectivity was a function of noncovalent interaction before covalent modification. With increased exposure to higher concentrations of BP and PA, multiple epitopes were detected on albumin, demonstrating that the multiplicity of hapten formation is a function of time and concentration. More importantly, we have demonstrated direct evidence that PA is a hapten accounting for the diastereoisomeric BP antigen formation in albumin isolated from the blood of patients receiving penicillin. Furthermore, PA was found to be more potent than BP with respect to stimulation of T cells from patients with penicillin hypersensitivity, illustrating the functional relevance of diastereoisomeric hapten formation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21680886      PMCID: PMC3164351          DOI: 10.1124/jpet.111.183871

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  29 in total

1.  Multiple reaction monitoring to identify sites of protein phosphorylation with high sensitivity.

Authors:  Richard D Unwin; John R Griffiths; Michael K Leverentz; Agnes Grallert; Iain M Hagan; Anthony D Whetton
Journal:  Mol Cell Proteomics       Date:  2005-05-27       Impact factor: 5.911

2.  Studies on crystalline dl-benzylpenicillenic acid.

Authors:  A H LIVERMORE; F H CARPENTER
Journal:  J Biol Chem       Date:  1948-09       Impact factor: 5.157

Review 3.  Role of T cells in drug allergies.

Authors:  W J Pichler; B Schnyder; M P Zanni; Y Hari; S von Greyerz
Journal:  Allergy       Date:  1998-03       Impact factor: 13.146

4.  Covalent adduction of human serum albumin by 4-hydroxy-2-nonenal: kinetic analysis of competing alkylation reactions.

Authors:  Matthew E Szapacs; James N Riggins; Lisa J Zimmerman; Daniel C Liebler
Journal:  Biochemistry       Date:  2006-09-05       Impact factor: 3.162

5.  Aspects of formation of the D-penicillamine-antigenic determinant from penicilloyl compounds.

Authors:  C H Schneider; C Pfeuti; A L de Weck
Journal:  Helv Chim Acta       Date:  1973-06-06       Impact factor: 2.164

6.  Penicillin allergy: the formation of the penicilloyl determinant.

Authors:  F R Batchelor; J M Dewdney; D Gazzard
Journal:  Nature       Date:  1965-04-24       Impact factor: 49.962

Review 7.  Molecular features of penicillin allergy.

Authors:  H U Weltzien; E Padovan
Journal:  J Invest Dermatol       Date:  1998-03       Impact factor: 8.551

Review 8.  Hypersensitivity reactions to beta-lactam antibiotics.

Authors:  Roland Solensky
Journal:  Clin Rev Allergy Immunol       Date:  2003-06       Impact factor: 8.667

9.  Formation of D-penicillamine-cysteine mixed disulphide by reaction of D-benzylpenicilloic acid with cystine.

Authors:  B B LEVINE
Journal:  Nature       Date:  1960-09-10       Impact factor: 49.962

10.  Specific sensitization of Lyt-1+2- T cells to spleen cells modified by the drug D-penicillamine or a stereoisomer.

Authors:  N Nagata; U Hurtenbach; E Gleichmann
Journal:  J Immunol       Date:  1986-01       Impact factor: 5.422

View more
  21 in total

1.  Characterization of the antigen specificity of T-cell clones from piperacillin-hypersensitive patients with cystic fibrosis.

Authors:  Sabah El-Ghaiesh; Manal M Monshi; Paul Whitaker; Rosalind Jenkins; Xiaoli Meng; John Farrell; Ayman Elsheikh; Daniel Peckham; Neil French; Munir Pirmohamed; B Kevin Park; Dean J Naisbitt
Journal:  J Pharmacol Exp Ther       Date:  2012-02-27       Impact factor: 4.030

2.  Mass spectrometric characterization of circulating covalent protein adducts derived from a drug acyl glucuronide metabolite: multiple albumin adductions in diclofenac patients.

Authors:  Thomas G Hammond; Xiaoli Meng; Rosalind E Jenkins; James L Maggs; Anahi Santoyo Castelazo; Sophie L Regan; Stuart N L Bennett; Caroline J Earnshaw; Guruprasad P Aithal; Ira Pande; J Gerry Kenna; Andrew V Stachulski; B Kevin Park; Dominic P Williams
Journal:  J Pharmacol Exp Ther       Date:  2014-06-05       Impact factor: 4.030

3.  Irreversible binding of an anticancer compound (BI-94) to plasma proteins.

Authors:  Nagsen Gautam; Rhishikesh Thakare; Sandeep Rana; Amarnath Natarajan; Yazen Alnouti
Journal:  Xenobiotica       Date:  2015-04-14       Impact factor: 1.908

4.  Chemical-free inactivated whole influenza virus vaccine prepared by ultrashort pulsed laser treatment.

Authors:  Shaw-Wei David Tsen; Nisha Donthi; Victor La; Wen-Han Hsieh; Yen-Der Li; Jayne Knoff; Alexander Chen; Tzyy-Choou Wu; Chien-Fu Hung; Samuel Achilefu; Kong-Thon Tsen
Journal:  J Biomed Opt       Date:  2015-05       Impact factor: 3.170

Review 5.  Immediate-type hypersensitivity drug reactions.

Authors:  Shelley F Stone; Elizabeth J Phillips; Michael D Wiese; Robert J Heddle; Simon G A Brown
Journal:  Br J Clin Pharmacol       Date:  2014-07       Impact factor: 4.335

6.  Staphylococcal enterotoxin B-derived haptens promote sensitization.

Authors:  Shao-Bo Yang; Tong-Li Li; Xiao Chen; Yun-Fang An; Chang-Qing Zhao; Jun-Bao Wen; Dao-Fa Tian; Zhong Wen; Min-Qiang Xie; Ping-Chang Yang
Journal:  Cell Mol Immunol       Date:  2012-09-03       Impact factor: 11.530

7.  The Effect of Inhibitory Signals on the Priming of Drug Hapten-Specific T Cells That Express Distinct Vβ Receptors.

Authors:  Andrew Gibson; Lee Faulkner; Maike Lichtenfels; Monday Ogese; Zaid Al-Attar; Ana Alfirevic; Philipp R Esser; Stefan F Martin; Munir Pirmohamed; B Kevin Park; Dean J Naisbitt
Journal:  J Immunol       Date:  2017-07-07       Impact factor: 5.422

Review 8.  Idiosyncratic adverse drug reactions: current concepts.

Authors:  Jack Uetrecht; Dean J Naisbitt
Journal:  Pharmacol Rev       Date:  2013-03-08       Impact factor: 25.468

9.  Definition of the Nature and Hapten Threshold of the β-Lactam Antigen Required for T Cell Activation In Vitro and in Patients.

Authors:  Xiaoli Meng; Zaid Al-Attar; Fiazia S Yaseen; Rosalind Jenkins; Caroline Earnshaw; Paul Whitaker; Daniel Peckham; Neil S French; Dean J Naisbitt; B Kevin Park
Journal:  J Immunol       Date:  2017-04-24       Impact factor: 5.422

Review 10.  Anaphylaxis to drugs: Overcoming mast cell unresponsiveness by fake antigens.

Authors:  Werner J Pichler
Journal:  Allergy       Date:  2020-09-01       Impact factor: 13.146

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.